These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17337182)

  • 81. Mechanism of Phosphodiesterase 5 inhibitor relief of prostatitis symptoms.
    Grimsley SJ; Khan MH; Jones GE
    Med Hypotheses; 2007; 69(1):25-6. PubMed ID: 17300876
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.
    Toque HA; Teixeira CE; Lorenzetti R; Okuyama CE; Antunes E; De Nucci G
    Eur J Pharmacol; 2008 Sep; 591(1-3):189-95. PubMed ID: 18593576
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Non-arteritic anterior ischemic optic neuropathy, PDE-5 inhibitors, and amiodarone: may there be a sex hormone effect for the eye?
    Verit A
    Med Hypotheses; 2007; 69(2):470-1. PubMed ID: 17280789
    [No Abstract]   [Full Text] [Related]  

  • 84. Pre-clinical evidence for the use of phosphodiesterase-5 inhibitors for treating benign prostatic hyperplasia and lower urinary tract symptoms.
    Hotston M; Shukla N; Bloor J; Persad R; Jeremy JY
    BJU Int; 2006 Dec; 98(6):1331-2. PubMed ID: 17125493
    [No Abstract]   [Full Text] [Related]  

  • 85. Commentary on adjunctive use of testosterone gel with sildenafil for erectile dysfunction.
    Morales A
    J Urol; 2008 May; 179(5 Suppl):S103. PubMed ID: 18405738
    [No Abstract]   [Full Text] [Related]  

  • 86. A high-throughput assay for cyclic nucleotide phosphodiesterases.
    Schilling RJ; Morgan DR; Kilpatrick BF
    Anal Biochem; 1994 Jan; 216(1):154-8. PubMed ID: 8135346
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Identification, synthesis and SAR of amino substituted pyrido[3,2b]pyrazinones as potent and selective PDE5 inhibitors.
    Owen DR; Walker JK; Jon Jacobsen E; Freskos JN; Hughes RO; Brown DL; Bell AS; Brown DG; Phillips C; Mischke BV; Molyneaux JM; Fobian YM; Heasley SE; Moon JB; Stallings WC; Joseph Rogier D; Fox DN; Palmer MJ; Ringer T; Rodriquez-Lens M; Cubbage JW; Blevis-Bal RM; Benson AG; Acker BA; Maddux TM; Tollefson MB; Bond BR; Macinnes A; Yu Y
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4088-91. PubMed ID: 19540112
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The role of PDE5-inhibitors in cardiopulmonary disorders: from basic evidence to clinical development.
    Guazzi M; Samaja M
    Curr Med Chem; 2007; 14(20):2181-91. PubMed ID: 17691956
    [TBL] [Abstract][Full Text] [Related]  

  • 89. PDE5 inhibitors and permanent visual loss.
    Tomsak R
    Int J Impot Res; 2005; 17(6):547-9. PubMed ID: 16193072
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The relationship between hypogonadism and erectile dysfunction.
    Hwang TI; Lin YC
    Int J Impot Res; 2008; 20(3):231-5. PubMed ID: 18305486
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [Some aspects of erectile dysfunction pathogenesis and treatment in patients with obesity].
    Ametov AS; Teodorovich OV; Kondrat'eva LV; Popova AIu
    Ter Arkh; 2006; 78(2):92-4. PubMed ID: 16613108
    [No Abstract]   [Full Text] [Related]  

  • 92. Unexpected insights into pelvic function following phosphodiesterase manipulation--what's next for urology?
    McVary KT
    Eur Urol; 2006 Dec; 50(6):1153-6. PubMed ID: 17045387
    [No Abstract]   [Full Text] [Related]  

  • 93. 1-(2-(2,2,2-trifluoroethoxy)ethyl-1H-pyrazolo[4,3-d]pyrimidines as potent phosphodiesterase 5 (PDE5) inhibitors.
    Tollefson MB; Acker BA; Jacobsen EJ; Hughes RO; Walker JK; Fox DN; Palmer MJ; Freeman SK; Yu Y; Bond BR
    Bioorg Med Chem Lett; 2010 May; 20(10):3125-8. PubMed ID: 20400309
    [TBL] [Abstract][Full Text] [Related]  

  • 94. 8-Aryl xanthines potent inhibitors of phosphodiesterase 5.
    Arnold R; Beer D; Bhalay G; Baettig U; Collingwood SP; Craig S; Devereux N; Dunstan A; Glen A; Gomez S; Haberthuer S; Howe T; Jelfs S; Moser H; Naef R; Nicklin P; Sandham D; Stringer R; Turner K; Watson S; Zurini M
    Bioorg Med Chem Lett; 2002 Sep; 12(18):2587-90. PubMed ID: 12182866
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E; Belardi D; Tocchetti CG; Vahebi S; Cormaci G; Ketner EA; Moens AL; Champion HC; Kass DA
    Circulation; 2007 Apr; 115(16):2159-67. PubMed ID: 17420342
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Counseling patients about sexual issues.
    Stimmel GL; Gutierrez MA
    Pharmacotherapy; 2006 Nov; 26(11):1608-15. PubMed ID: 17064206
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Optimization of the aminopyridopyrazinones class of PDE5 inhibitors: discovery of 3-[(trans-4-hydroxycyclohexyl)amino]-7-(6-methoxypyridin-3-yl)-1-(2-propoxyethyl)pyrido[3,4-b]pyrazin-2(1H)-one.
    Hughes RO; Walker JK; Rogier DJ; Heasley SE; Blevis-Bal RM; Benson AG; Jacobsen EJ; Cubbage JW; Fobian YM; Owen DR; Freskos JN; Molyneaux JM; Brown DL; Acker BA; Maddux TM; Tollefson MB; Moon JB; Mischke BV; Rumsey JM; Zheng Y; MacInnes A; Bond BR; Yu Y
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5209-13. PubMed ID: 19631533
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours].
    Deng SM
    Zhonghua Nan Ke Xue; 2008 Sep; 14(9):857-60. PubMed ID: 18998474
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Synthesis of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole analogues as novel antiplatelet agents.
    Lee FY; Lien JC; Huang LJ; Huang TM; Tsai SC; Teng CM; Wu CC; Cheng FC; Kuo SC
    J Med Chem; 2001 Oct; 44(22):3746-9. PubMed ID: 11606139
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction.
    Axilrod AC
    Curr Med Res Opin; 2007 Dec; 23(12):3189-98. PubMed ID: 17991309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.